![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, August 04, 2021 12:45:45 PM
"The NanoLogix technology's additional ability to detect the presence of the neutralizing antibody to the virus is critical in determining the need for vaccination and the effectiveness and longevity of the antibodies that neutralize the infections.
This is vital because COVID-19 vaccines will initially be in limited supply in the US and internationally. Individuals will need to be tested for neutralizing antibodies prior to receiving the vaccine. Jonathan Faro, PhD, MD, and Medical Director of NanoLogix has stated: "As a physician who is exposed daily to the virus, I would not in good conscience want to receive the vaccine without first being tested for those neutralizing antibodies. To do so would be to divert scarce vaccine resources from those who need them.” This is also of critical importance because the asymptomatic carrier rate in the population may be as high as 40%—generating a significant rate of potential “invisible” transmission to individuals exposed to those carrier
Seems like vaccines are rolling out pretty fast, where is this test to detect for neutralizing antibody at ?
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM